North America Diet Pills Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis – By Product Type (Prescription, Over the Counter Drugs, and Herbal Supplements), Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills, and Others), Age Group (Children and Adults), and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores)


No. of Pages: 105    |    Report Code: TIPRE00029155    |    Category: Life Sciences

North America Diet Pills Market
Buy Now

The North America diet pills market is expected to grow from US$ 466.95 million in 2021 to US$ 949.03 million by 2028; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028.

 

Consumers' knowledge about the importance of well-being and disease prevention increases with the rising availability and application of online medicine portals and health organization websites for consultation. They have become more health-conscious and taking a proactive approach to disease treatment and prevention. Moreover, the growing popularity of fitness, bodybuilding, and specialist sports ("from health to fit") among people aged between 20 and 40 is boosting the need for diet pills and supplements that help them achieve their aesthetic goals and improve their performance. The number of gym and fitness enthusiasts has increased rapidly in the last decade. Several fitness coaches and professionals recommend the intake of diet pills for weight loss. Diet pill industry players across North America are likely to introduce new varieties of diet pills in the next decade.  

 

With the new features and technologies, vendors attract new customers to grow their footprints in emerging markets. This factor is likely to drive the North America Diet Pills market. The North America Diet Pills market is expected to grow at a substantial CAGR during the forecast period.

 

North America Diet Pills Market Revenue and Forecast to 2028 (US$ Million

)


North America Diet Pills Market Revenue and Forecast to 2028 (US$ Million)

North America Diet Pills Market Segmentation     

 

The North America diet pills market is segmented into product type, application, age group, distribution channel, and country. Based on product type, the North America diet pills market is segmented into prescription, herbal supplements, and over the counter drugs. The prescription segment dominated the market in 2020. Based on application, the North America diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. The appetite suppression segment led the market in 2020. Based on age group, the North America diet pills market is bifurcated into adults and teenagers. The adults segment dominated the market in 2020. Based on distribution channel, the North America diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug stores. The hospital pharmacies segment led the market in 2020. Based on country, the North America diet pills market is segmented into the US, Canada, and Mexico. The US segment dominated the market in 2020.  

 

Pfizer Inc. (Arena Pharmaceutical GMBH), Novo Nordisk A/S, Gelesis, VIVUS LLC, GlaxoSmithKline plc, Lovate Health Sciences International Inc., TEVA  Pharmaceutical Industries LTD, Currax  Pharmaceutical LLC, Chong’s Health Care, and Zoller Laboratories are among the leading companies operating in the North America Diet

Pills

market..


North America Diet Pills Strategic Insights

Strategic insights for the North America Diet Pills provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/north-america-diet-pills-market-strategic-framework.webp
Get more information on this report

North America Diet Pills Report Scope

Report Attribute Details
Market size in 2021 US$ 466.95 Million
Market Size by 2028 US$ 949.03 Million
Global CAGR (2021 - 2028) 10.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Prescription
  • Over the Counter Drugs
  • Herbal Supplements
By Application
  • Appetite Suppression
  • Fat Blocking
  • Metabolism Raising Pills
By Age Group
  • Children
  • Adults
By Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Drug Stores
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Pfizer Inc. (Arena Pharmaceutical GMBH)
  • Novo Nordisk A/S
  • Gelesis
  • VIVUS LLC
  • GlaxoSmithKline plc
  • Lovate Health Sciences International Inc.
  • TEVA Pharmaceutical Industries LTD
  • Currax Pharmaceutical LLC
  • Chong’s Health Care
  • Zoller Laboratories
  • Get more information on this report

    North America Diet Pills Regional Insights

    The geographic scope of the North America Diet Pills refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/north-america-diet-pills-market-geography.webp
    Get more information on this report

    The List of Companies - North America Diet Pills Market

    1. Pfizer Inc. (Arena Pharmaceutical GMBH)
    2. Novo Nordisk A/S
    3. Gelesis
    4. VIVUS LLC
    5. GlaxoSmithKline plc
    6. Lovate Health Sciences International Inc.
    7. TEVA  Pharmaceutical Industries LTD
    8. Currax  Pharmaceutical LLC
    9. Chong’s Health Care
    10. Zoller Laboratories
    Frequently Asked Questions
    How big is the North America Diet Pills Market?

    The North America Diet Pills Market is valued at US$ 466.95 Million in 2021, it is projected to reach US$ 949.03 Million by 2028.

    What is the CAGR for North America Diet Pills Market by (2021 - 2028)?

    As per our report North America Diet Pills Market, the market size is valued at US$ 466.95 Million in 2021, projecting it to reach US$ 949.03 Million by 2028. This translates to a CAGR of approximately 10.7% during the forecast period.

    What segments are covered in this report?

    The North America Diet Pills Market report typically cover these key segments-

    • Product Type (Prescription, Over the Counter Drugs, Herbal Supplements)
    • Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills)
    • Age Group (Children, Adults)
    • Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Drug Stores)

    What is the historic period, base year, and forecast period taken for North America Diet Pills Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Diet Pills Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in North America Diet Pills Market?

    The North America Diet Pills Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Pfizer Inc. (Arena Pharmaceutical GMBH)
  • Novo Nordisk A/S
  • Gelesis
  • VIVUS LLC
  • GlaxoSmithKline plc
  • Lovate Health Sciences International Inc.
  • TEVA Pharmaceutical Industries LTD
  • Currax Pharmaceutical LLC
  • Chong’s Health Care
  • Zoller Laboratories
  • Who should buy this report?

    The North America Diet Pills Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Diet Pills Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now